Sub menu

Vaccines

Fluzone High-Dose Quadrivalent

Details for Fluzone High-Dose Quadrivalent (influenza) vaccine and its components.

Recently added

This page was added on 02 May 2022.

Updates made

This page was updated on [date-counter-updated-date]. View history of updates

Sponsor
Sanofi-Aventis Australia
Administration route
Intramuscular injection
Vaccine group
Adults aged ≥60 years only
Description:

Registered for use in people aged ≥60 years.

Quadrivalent inactivated influenza vaccine, split virion.

Each 0.7 mL monodose pre-filled syringe contains:

  • 60 µg haemagglutinin of each of the 4 recommended influenza virus strains

May contain traces of:

  • formaldehyde (≤ 140 µg)
  • ovalbumin (≤ 1 µg)

For Product Information and Consumer Medicine Information about Fluzone High-Dose Quadrivalent visit the Therapeutic Goods Administration website.

Additional vaccine information

For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.

Related diseases
Influenza (flu)

Page history

Last updated
Last reviewed

Help us improve the Australian Immunisation Handbook

Printed content may be out of date. For up to date information, always refer to the digital version:

https://immunisationhandbook.health.gov.au/vaccines/fluzone-high-dose-quadrivalent

All vaccines

Link copied

Link, share or bookmark directly to this section of the page.